C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2002
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002	US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002	US6469010 Medicament for the alleviation or treatment of symptom derived from the ischemic disease and compound useful thereof
10/22/2002	US6468504 Composition comprising methylphenidate and another drug
10/17/2002	WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002	WO2002081450A1 Process for producing desmethylcyproheptadine and method of purification
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080857A2 Polymorphs of fexofenadine hydrochloride
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2002022582A3 Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide
10/17/2002	US20020151724 Such as 1-((4-methoxybenzoyl-D-phenylglycinyl))-4-((isopropylamino)methyl)piperidine hydrochloride as anticoaggulants useful in the treatment of cardiovascular disorders such as thrombosis
10/17/2002	US20020151717 Novel processes for the preparation or (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
10/17/2002	US20020151666 Such as 2-(1-tert- butoxycarbonylpiperidin-2-yl)ethyl 5-norbornene-2-carboxylate; photolithography; etching/heat resistance; semiconductors
10/17/2002	US20020151595 Carboxylic acid amides having antithrombotic activity
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002	US20020151565 Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151552 Novel compounds
10/17/2002	US20020151547 Substituted phenyl-piperidine methanone compounds
10/17/2002	US20020151545 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer
10/17/2002	US20020151539 Novel heterocyclic compounds
10/17/2002	US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002	DE10117823A1 New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
10/17/2002	CA2444456A1 Polymorphs of fexofenadine hydrochloride
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442904A1 Benzamidine derivative
10/16/2002	EP1249238A2 Topical pharmaceutical composition comprising betanechol
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248777A2 Tricyclic compounds with antiviral activity
10/16/2002	EP1248770A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	CN1375058A Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures
10/16/2002	CN1374949A 毒蕈碱拮抗剂 Muscarinic antagonist
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/16/2002	CN1374296A Production process of caprolactam with waste nylon 6
10/16/2002	CN1092655C 哌啶衍生物 Piperidine derivatives
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002	US6465645 Containing triazine groups and n-alkyloxypiperidine groups; candle wax which is effectively stabilized against discoloration and fading
10/15/2002	US6465490 Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester
10/15/2002	US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002	US6465487 Inhibition of membrane-associated viral replication
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/10/2002	WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002	WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002	WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079158A1 Novel amlodipine camsylate and method for preparing thereof
10/10/2002	WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002	WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002	WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002	WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002	WO2002057215A3 Sodium channel modulators
10/10/2002	WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002	WO2002048108B1 New process for the preparation diaryl-4-amino-piperidinyl compounds
10/10/2002	US20020147359 Neurokinin antagonist; antiinflammatory agents, antiallergens
10/10/2002	US20020147337 Antilipemic agents; chemical interemdiates
10/10/2002	US20020147336 Glucocorticoid receptor modulators
10/10/2002	US20020147222 Brain disorders; Alzheimer's disease
10/10/2002	US20020147219 Neurokinin antagonists
10/10/2002	US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002	US20020144358 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment
10/10/2002	DE10117730A1 One-pot reaction of amines, useful for preparing e.g. cyclic secondary amines or alcohols, useful as pharmaceutical intermediates, by oxidation with lysine oxidase then reduction
10/10/2002	DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002	CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002	CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002	EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002	EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002	EP1246801A2 Methods for the syntheses of alfentanil, sufentanil and remifentanil
10/09/2002	EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002	EP1246795A2 Antibacterial agents
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP0874836B1 Sulfonamide inhibitors of matrix metalloproteinases
10/09/2002	EP0772590B1 Thrombin inhibitors
10/09/2002	CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002	CN1373754A Antibacterial agents
10/09/2002	CN1373753A Mutual salt of amlodipine and atorvastatin
10/09/2002	CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002	CN1373660A Method for treating chronic pain using MEK inhibitors
10/08/2002	US6462197 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
10/08/2002	US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002	US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002	US6462042 Tumor necrosis factor alpha converting enzyme inhibitors; inflammatory diseases, autoimmune diseases, cancer, cardio-vascular diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, neurodegeneration, alzheimer's disease, stroke
10/08/2002	US6462034 Multibinding compounds containing a symetrical diaminotetra-etherdodecane ring with two secondary amide and additional substituents; voltage gated sodium channel modulators; long duration
10/08/2002	US6462023 Cytostatic agents
10/07/2002	WO2001076598A1 Stabilized pharmaceutical compositions containing calcium channel blockers

1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 380